Concepedia

Franz Gruber

FG

Statistics

Publications

16

Citations

1.8K

H-Index

13

Active since

2005

Affiliations

UiT The Arctic University of Norway(Current)

Helsinki University Hospital

St Olav's University Hospital

University Hospital of North Norway

Uppsala University Hospital

Franz Gruber is an author at UiT The Arctic University of Norway specializing in oncology, medicine, and molecular oncology.

Publications per year

2005–2024

16

Publications

16

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 611 citations · Full text

Medicine, Oncology, Pharmacology +11

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán et al. · Blood · 2008 · 443 citations · Full text

Medicine, Hematology, Oncology +13

Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Bengt Simonsson, Tobias Gedde‐Dahl, Berit Markevärn et al. · Blood · 2011 · 194 citations · Full text

Medicine, Hematology, Oncology +10

Intracellular and Surface Distribution of Monocyte Tissue Factor

Elena M. Egorina, Mikhail A. Sovershaev, Geir Bjørkøy et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 133 citations · Full text

Life Sciences, Cell Biology, Immunology +12

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Henrik Hjorth‐Hansen, Jesper Stentoft, Johan Richter et al. · Leukemia · 2016 · 72 citations

Medicine, Oncology, Pharmacology +10

1–5 of 16